Mark Kaye - 02 Oct 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Oct 2026, 16:02:46 UTC
Prior SEC filing
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Mark Kaye filed Form 4 for Elevance Health, Inc. (ELV) on 06 Oct 2026.

Key facts

  • This page summarizes Mark Kaye's Form 4 filing for Elevance Health, Inc. (ELV).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Oct 2026, 16:02.

Change

  • Previous filing in this sequence was filed on 03 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001748691 Primary reporting owner

Kaye Mark

Relationship
EVP & CFO
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Signature date
06 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Tax liability

Transaction value
Shares
-4,161
Change %
-13%
Price
$386.43*
Shares after
27,876
Date
02 Oct 2026
Ownership
Direct
Footnotes
F1
ELV transaction

Common Stock

Award

Transaction value
Shares
+2,627
Change %
+9.4%
Price
$0.000000*
Shares after
30,503
Date
02 Oct 2026
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Footnote F2

Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .